BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16781689)

  • 1. Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats.
    de Meira Santos Lima M; Braga Reksidler A; Marques Zanata S; Bueno Machado H; Tufik S; Vital MA
    Brain Res; 2006 Jul; 1101(1):117-25. PubMed ID: 16781689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations.
    Ferro MM; Bellissimo MI; Anselmo-Franci JA; Angellucci ME; Canteras NS; Da Cunha C
    J Neurosci Methods; 2005 Oct; 148(1):78-87. PubMed ID: 15939479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease.
    Reksidler AB; Lima MM; Dombrowski P; Andersen ML; Zanata SM; Andreatini R; Tufik S; Vital MA
    J Neurosci Methods; 2008 Jan; 167(2):268-77. PubMed ID: 17931705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats.
    Reksidler AB; Lima MM; Zanata SM; Machado HB; da Cunha C; Andreatini R; Tufik S; Vital MA
    Eur J Pharmacol; 2007 Apr; 560(2-3):163-75. PubMed ID: 17320073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
    Kondoh T; Bannai M; Nishino H; Torii K
    Exp Neurol; 2005 Mar; 192(1):194-202. PubMed ID: 15698634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.
    Da Cunha C; Wietzikoski EC; Ferro MM; Martinez GR; Vital MA; Hipólide D; Tufik S; Canteras NS
    Behav Brain Res; 2008 Jun; 189(2):364-72. PubMed ID: 18328580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model.
    Kang JM; Park HJ; Choi YG; Choe IH; Park JH; Kim YS; Lim S
    Brain Res; 2007 Feb; 1131(1):211-9. PubMed ID: 17173870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
    Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
    Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
    Reglodi D; Tamás A; Lubics A; Szalontay L; Lengvári I
    Regul Pept; 2004 Dec; 123(1-3):85-94. PubMed ID: 15518897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
    Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Przybyłkowski A; Gromadzka G; Członkowska A; Członkowski A
    Neuroimmunomodulation; 2007; 14(5):255-65. PubMed ID: 18196934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats.
    Capitelli C; Sereniki A; Lima MM; Reksidler AB; Tufik S; Vital MA
    Eur J Pharmacol; 2008 Oct; 594(1-3):101-8. PubMed ID: 18674531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats.
    Moghaddamt HF; Ardestani MS; Saffari M; Navidpour L; Shafiee A; Rahmim A
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):293-6. PubMed ID: 18764909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.
    Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Belzunegui S; Izal-Azcárate A; López B; Marcilla I; Luquin MR
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):26-36. PubMed ID: 19104449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion.
    Srinivasan J; Schmidt WJ
    Synapse; 2004 Mar; 51(3):213-8. PubMed ID: 14666519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.
    Vlamings R; Visser-Vandewalle V; Koopmans G; Joosten EA; Kozan R; Kaplan S; Steinbusch HW; Temel Y
    Neuroscience; 2007 Sep; 148(3):815-23. PubMed ID: 17706885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.